0001572426-16-000194.txt : 20160701 0001572426-16-000194.hdr.sgml : 20160701 20160701202023 ACCESSION NUMBER: 0001572426-16-000194 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160701 FILED AS OF DATE: 20160701 DATE AS OF CHANGE: 20160701 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nexvet Biopharma plc CENTRAL INDEX KEY: 0001618561 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: UNIT 5, SRAGH TECHNOLOGY PARK STREET 2: RAHAN ROAD CITY: TULLAMORE , CO. OFFALY STATE: L2 ZIP: R35 FR98 BUSINESS PHONE: 353 1 215 8100 MAIL ADDRESS: STREET 1: UNIT 5, SRAGH TECHNOLOGY PARK STREET 2: RAHAN ROAD CITY: TULLAMORE , CO. OFFALY STATE: L2 ZIP: R35 FR98 FORMER COMPANY: FORMER CONFORMED NAME: NEXVET BIOPHARMA Ltd DATE OF NAME CHANGE: 20140903 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Heffernan Mark CENTRAL INDEX KEY: 0001632439 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36828 FILM NUMBER: 161747904 MAIL ADDRESS: STREET 1: C/O NEXVET BIOPHARMA PLC STREET 2: NATL INST, FOSTERS AVENUE, MOUNT MERRION CITY: BLACKROCK STATE: L2 ZIP: 00000 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2016-07-01 0001618561 Nexvet Biopharma plc NVET 0001632439 Heffernan Mark C/O NEXVET BIOPHARMA PLC UNIT 5, SRAGH TECHNOLOGY PARK, RAHAN RD TULLAMORE L2 R35 FR98 IRELAND 0 1 0 0 Chief Executive Officer Ordinary Shares 2016-07-01 4 M 0 4833 .125 A 24167 D Ordinary Shares 2016-07-01 4 M 0 25000 .125 A 49167 D Ordinary Shares 243587 I By Mark Andrew and Patricia Louise Heffernan <M&T Heffernan A/C> Option to Purchase Shares .125 2016-07-01 4 M 0 4833 0 D 2019-07-01 Ordinary Shares 4833 4833 D Restricted Share Units .125 2016-07-01 4 M 0 25000 0 D 2020-07-01 Ordinary Shares 25000 75000 D The reporting person and his spouse share voting and dispositive power with respect to these reported securities. The remaining 4,833 options to purchase shares will vest and become exercisable on 7/1/17. Previously reported as indirectly held. 25,000 of the Restricted Share Units shall vest and become convertible on each of 7/1/17, 7/1/18 and 7/1/19, in each case subject to payment of the nominal value per share to Issuer within 30 days of vesting. /s/ Mark Heffernan by Geraldine T. Farrell, Attorney-in-Fact 2016-07-01